Response to “Biologic, Demographic, and Social Factors Affecting Triple Negative Breast Cancer Outcomes”

I would like to thank Turkman, Sakibia Opong, Harris, and Knobf (2015) for the excellent review of triple negative breast cancer and practice implications for oncology nurses. The authors correctly note that triple negative breast cancer can be associated with an increased risk of harboring a BRCA1 mutation. Individuals with triple negative breast cancer also are at risk for a number of other germline mutations, including mutations in the PALB2, CHEK2, BARD1, ATM, PTEN, BRCA2, and TP53 genes.